The Globalist

How could the United States outsource military operations in Iraq to keep human and monetary costs manageable?

Should the U.S. pharma industry worry that the rebellion against prescription drug costs will turn into a replay of 1773?

Can the United States reckon on full EU support to rebuild Iraq in the aftermath of war in that country?